Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $112.6000 (-0.46%) ($112.2400 - $114.2700) on Tue. May. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 31 | Latest Price | $112.6000(-0.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). VXX(-21%) TLT(-15%) VIXM(-9%) IFRA(-8%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
Resistance Level | $122.28 | 5 Day Moving Average | $116.44(-3.3%) | 10 Day Moving Average | $119.83(-6.03%) | 20 Day Moving Average | $122.28(-7.92%) | To recent high | -12.9% | To recent low | 6.3% | Market Cap | $1.81b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |